Vivimed Labs Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 336.42 million compared to INR 442.24 million a year ago. Revenue was INR 358.42 million compared to INR 443.74 million a year ago. Net loss was INR 202.98 million compared to INR 220.31 million a year ago. Basic loss per share from continuing operations was INR 2.45 compared to INR 2.66 a year ago.
For the six months, sales was INR 689.93 million compared to INR 943.3 million a year ago. Revenue was INR 713.05 million compared to INR 945.62 million a year ago. Net loss was INR 346.59 million compared to INR 442.34 million a year ago. Basic loss per share from continuing operations was INR 4.18 compared to INR 5.33 a year ago.